top of page

Original articles

​

  1. RH Pichler, TF Andoh, C Hugo, SJ Shankland, M Nangaku, V Ophascharoensuk, C Giachelli, C Zachem, G Eng, CE Alpers, WM Bennett, WG Couser, RJ Johnson. Differential expression of nitric oxide synthase (NOS) isoforms in CSA nephropathy: Potential regulation by osteopontin. Journal of the American Society of Nephrology Volume 7, September 1996, page 1763.

  2. V Ophascharoensuk, RJ Johnson, JM Roberts, WG Couser, SJ Shankland. Critical role for cyclin kinase inhibitor (CKI), p27, in proliferative glomerulonephritis (GN) in vivo. Nephrology Volume 3, Supplement 1, May 1997, page S242.

  3. V Ophascharoensuk, CM Giachelli, L Liaw, SJ Shankland, WG Couser, RJ Johnson. Osteopontin (OPN) mediates early macrophage influx in renal interstitial inflammation: A study in OPN knockout mice. Journal of the American Society of Nephrology Volume 8, September 1997, page 481A.

  4. V Ophascharoensuk, ML Fero, JM Roberts, SJ Shankland. The severity of crescentic glomerulonephritis (GN) in mice is determined by levels of the cyclin kinase inhibitor (CKI), p27. Journal of the American Society of Nephrology Volume 8, September 1997, page 427A.

  5. V Ophascharoensuk. Intravenous Pulse Cyclophosphamide Maintained Renal Functions and Improved Proteinuria in Patients with Diffuse Proliferative Lupus Nephritis: One-Year Follow-Up. Journal of the Nephrology Society of Thailand 1999.

  6. V Ophascharoensuk. Mycophenolate Mofetil (CellCept) Limits Renal Damage in Cyclophosphamide–Resistant Severe Lupus Nephritis. Journal of the Nephrology Society of Thailand 1999.

  7. V Ophascharoensuk. Focal Segmental Glomerulosclerosis: An Important Cause of Chronic Renal Failure in Thailand. Journal of the Nephrology Society of Thailand 2000.

  8. Chiewchanvit S, Noppakun K, Kanchanarattanakorn K. Mucocutaneous complications of chemotherapy in 74 patients from Maharaj Nakorn Chiang Mai Hospital. J Med Assoc Thai 2004 May;87(5):508-14.

  9. Lumlertgul D, Noppakun K, Rojanasthien N, Kanchanarattanakorn K, Jittikanont S, Bunnachak D, Ophascharoensuk V. Pharmacokinetic study of the combination of tacrolimus and fluconazole in Thai renal transplant patients. J Med Assoc Thai 2006 Aug;89(S2):S72-8.

  10. Noppakun K, Naohiko I, Gupta S. Stem cell and kidney regeneration. Proc Indian Natn Sci Acad2010;76(2):1-4.

  11. Noppakun K, Cosio F, Dean P, Taler S, Wauters R, Grande J. Living donor age and kidney transplant outcomes. Am J Transplant 2011 Jun;11(6):1279-86.

  12. Gupta S, Li S, Abedin Md. J, Noppakun K, Wang L, Kaur T, Najafian B, Rodrigue C MP, Clifford SJ. Prevention of acute kidney injury by tauroursodeoxycholic acid in rat and cell culture models. PLoS ONE 2012;7(11): e48950.

  13. Lumlertgul N, Noppakun K. Role of Rhesis (Rh) protein in ammonia excretion in the kidney. J Nephrol Soc Thailand 2013;19(4):11-13.

  14. Pongpirul K, Pongpirul WA, Avihingsanon Y, Noppakun K, Ingsathit A, Pongskul C, Premasthian N, Lumpaopong A, Vareesangthip K, and Sumethkul V. Potential impact of Thai kidney transplant program on immunosuppressive utilization: An analysis of the national transplant registry. Transplant Proc 2014;46:422-424.

  15. Chantaramungkorn T, Noppakun K. Proton pump inhibitor-induced acute tubulointerstitial nephritis. J Nephrol Soc Thailand 2014;20(3):16-24.

  16. Noppakun K, Ingsathit A, Pongsakul C, Premasthian N, Avihingsanon Y, Lumpaopong A, Vareesangthip K, and Sumethkul V. A 25-year experience of kidney transplantation in Thailand: Report from the Thai Transplant Registry. Nephrology 2015;20:177-183.

  17. Siriplubpla N, Noppakun K. Clinical parameter versus bioimpedance spectroscopy as ultrafiltration volume assessment in patients with acute kidney injury: A single-center, double-blinded, randomized, non-inferiority study. J Nephrol Soc Thailand 2015;21(3):43-50.

  18. Nochaiwong S, Chidchanok R, Awiphan R, Dandecha P, Noppakun K, Phrommintikul A. Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis. Open Heart 2016;3:e000441. doi:10.1136/openhrt-2016-000441.

  19. Siriplubpla W, Noppakun K, Ophascharoensuk V. The effects of intravenous fluid replacement on metabolic acidosis and kidney function: comparison between normal saline solution and balanced electrolyte crystalloid solution. J Nephrol Soc Thailand 2016;22(1):31-41.

  20. Nochaiwong S, Ruengorn C, Awiphan R, Panyathong S, Noppakun K, Chongruksut W, Chiewchanvit S. Development of a multidimensional assessment tool for uraemic pruritus: Uraemic Pruritus in Dialysis Patients (UP-Dial). Br J Dermatol. 2017 Jun;176(6):1516-1524.

  21. Nochaiwong S, Ruengorn C, Awiphan R, Koyratkoson K, Chaisai C, Noppakun K, Chongruksut W, Thavorn K. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant. 2018 Feb 1;33(2):331-342.

  22. Wangkaew S, Lertthanaphok S, Puntana S, Noppakun K. Risk factors and outcome of Thai patients with scleroderma renal crisis: a disease duration-matched case control study. Int J Rheum Dis. 2017 Oct;20(10):1562-1571.

  23. Srifuengfung M, Noppakun K, Srisurapanont M. Depression in Kidney Transplant Recipients: Prevalence, Risk Factors, and Association with Functional Disabilities. J NervMent Dis. 2017 Oct;205(10):788-792.

  24. Nochaiwong S, Ruengorn C, Koyratkoson K, Chaisai C, Awiphan R, Thavorn K, Noppakun K, Suteeka Y, Panyathong S, Chongruksut W, Nanta S, Chiewchanvit S. Clinical interpretation of the Uremic Pruritus in Dialysis Patients (UP-Dial) scale: a novel instrument for the assessment of uremic pruritus. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1188-1194.

  25. Nochaiwong S, Ruengorn C, Koyratkoson K, Thavorn K, Awiphan R, Chaisai C, Phatthanasobhon S, Noppakun K, Suteeka Y, Panyathong S, Dandecha P, Chongruksut W, Nanta S; Thai Renal Outcomes Research (THOR) Investigators. A Clinical Risk Prediction Tool for Peritonitis-Associated Treatment Failure in Peritoneal Dialysis Patients. Sci Rep. 2018 Oct 4;8(1):14797.

  26. Rovin BH, Solomons N, Pendergraft III WF, Dooley MA, Tumlin J, Romero-Diaz J, Lysenko L, Navarra SV, Huizinga RB, Noppakun K, and the AURA-LV Study Group. A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney Int. 2019 Jan;95(1):219-231.

  27. Udomkarnjananun S, Townamchai N, Kerr SJ, Tasanarong A, Noppakun K, Lumpaopong A, Prommool S, Supaporn T, Avihingsanon Y, Praditpornsilpa K, Eiam-Ong S. The First Asian Kidney Transplantation Prediction Models for Long-Term Patient and Allograft Survival. Transplantation. 2019 Aug 12. doi: 10.1097/TP.0000000000002918. [Epub ahead of print]

  28. Yoowannakul S, Tangvoraphonkchai K, Vongsanim S, et al. Difference in the prevalence of sarcopenia in haemodialysis patients: effects of gender and ethnicity. J Hum Nutr Diet 2018; 31(5):689-96

  29. Abro A, Delicata LA, Vongsanim S, Davenport A. Difference in the prevalence of sarcopenia in peritoneal dialysis patients using hand grip strength and appendicular lean mass: depends upon guideline definitions. Eur J Clin Nutr2018; 72(7):993-9

  30. Vongsanim S, Davenport A. Estimating Dietary Protein Intake in Peritoneal Dialysis Patients: The Effect of Ethnicity. Perit Dial Int 2018; 38(5):384-7

  31. Vongsanim S, Davenport A. Comparison of skin autofluorescence, a marker of tissue advanced glycation end-products in peritoneal dialysis patients using standard and biocompatible glucose containing peritoneal dialysates. Nephrology(Carlton) 2019;24:835-40

  32. Vongsanim S, Salame C, Eaton S, et al. Differences between Measured Total Nitrogen Losses in Spent Peritoneal Dialysate Effluent and Estimated Nitrogen Losses. J Ren Nutr2019:29(3);243-7

  33. Vongsanim S, Davenport A. The effect of gender on survival for hemodialysis patients: Why don’t women live longer than men? Semin Dial. 2019;0:0-16

  34. Vongsanim S, Davenport A. Factors associated with systolic hypertension in peritoneal dialysis patients. J Nephrol. 2019. Aug 10 [Epub ahead of print]

  35. Bannchak D, Noppakun K, Suteeka Y. TRK-100STP Phase IIb/III clinical study- Chronic renal failure (Primary glomerular disease/ nephrosderosis).

  36. Lumlertgul D, Jittikanont S, Suteeka Y. A randomized, controlled, open-label, multi-centre, parallel-group study to assess all-cause mortality and cardiovascular morbidity in patients with chronic kidney disease on dialysis and those not on renal replacement therapy under treatment with MIRCERA® or reference ESAs.

  37. Noppakun K, Suteeka Y. A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects with IgA Nephropathy.

  38. Lumlertgul D, Suteeka Y, Tumpong S, Bunnachak D, Boonkaew S. Double Filtration Plasmapheresis in Different Diseases in Thailand. Therapeutic Apheresis and Dialysis 2013; 17(1):99-116.

  39. Vareesangthip K, Thitiarchakul S, Kanjanakul I, Sumethkul V, Krairittichai U, Chittinanda A, Bunnachak D. Efficasy and safety of enoxaparin during hemodialysis: results from the HENOX study. J Med Assoc Thai. 2011 Jan;94(1):21-6.

bottom of page